• Tourists will be able to purchase medicines if they are in possession of a prescription from a licensed medical practitioner
  • Initiative is part of ongoing efforts by Aster DM Healthcare to continue to provide the highest quality health and wellness services to the community during the COVID-19 outbreak

Dubai, UAE: Aster Pharmacy, part of Aster DM Healthcare - one of the largest private, integrated healthcare service providers across the GCC, has announced that it will offer medicines at cost price to visitors who are stranded in the UAE due to the COVID-19 pandemic.

There are currently a large number of people stuck in the UAE as a result of COVID-19 issues, many of whom do not possess health insurance: this is especially worrying for those that have chronic conditions requiring ongoing medical support - in addition to visitors with acute illness that require immediate medication. Aster has been receiving several requests from various consulates to assist their citizens to avail prescription medicines – many of which can be very expensive to purchase privately.  As a result, Aster Pharmacy will provide medicines at cost price to visitors who can provide proof of their identity and a visit visa in addition to a prescription from a licensed medical practitioner. If prescriptions have been prepared by doctors outside of the UAE, alternative medicines will be provided at cost price.

All prescription medicines (that are legally permitted in the UAE) can be accessed as part of this initiative. Controlled medicines will require a prescription from a UAE doctor.  Generic drugs will be offered in the first instance over branded medications and in certain circumstances visitors may even be allowed to buy a refill of their medication for a chronic condition without a prescription on presentation of proof of treatment e.g., old prescriptions, packaging etc. Children under the age of 16 will not be given medication without a prescription. Patients must attend the pharmacy in person to buy their medicines and can do so at any of Aster’s pharmacies in the UAE.

Speaking about the initiative Mr. Jobilal Vavachan, CEO of Aster Primary Healthcare, said: “As the UAE continues to experience challenges due to the COVID-19 pandemic, it is crucial that the community comes together to assist the citizens, residents and visitors who have been most affected by the crisis.  We understand that the situation is uncertain and fast-changing, and this can be especially worrying for those that are stranded in the country without access to their usual healthcare services and provisions. Aster Healthcare is deeply committed to offering its full support, wherever possible, to ensure that the health and wellbeing of every person in the UAE is protected during these unprecedented times.  We are constantly looking for ways to further help those that are facing healthcare challenges due to the pandemic; and are dedicated to delivering world-class, accessible and cost-effective care to those that need it most.”

The initiative is a part of Aster DM Healthcare’s ongoing efforts to ensure the collective health of the community during the COVID-19 crisis.  Aster is already offering free telemedicine advisory to all members of the public in relation to any COVID-19 concerns. The Group is also conducting more than 200 “virtual” consultations per day in areas including internal medicine, gastroenterology, pulmonology and endocrinology.  The service is proving extremely useful in managing chronic symptoms for patients who are unable to attend the clinic at present. Patients that require laboratory testing can even avail Aster’s ‘Lab at Home’ service while restrictions on movement continue to apply.

-Ends-

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence the Company is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through its 25 hospitals, 116 clinics and 238 pharmacies. These are manned by our 20,329+ workforce (including approximately 230 doctors on fee for service basis) from across the geographies that we are present in, delivering on a simple yet strong promise to its people: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.

For more information about us, please visit www.asterdmhealthcare.com or contact:
Lavanya Mandal                                                                                                  
Head of PR and Internal Communications                                          
Aster DM Healthcare
Tel:  +971 528126577
Email: lavanya.mandal@asterdmhealthcare.com 

Bejoy Changarath
Assistant General Manager - PR & Media Relations
Aster DM Healthcare
Tel: +971 524073559
Email: bejoy.changarath@asterdmhealthcare.com 

DISCLAIMER:

Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. Aster DM Healthcare will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

Send us your press releases to pressrelease.zawya@refinitiv.com 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.